-
-
-
-
-
-
-
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on Caribou Biosciences Inc. (CRBU), 'Strong Cash Position and Attractive Entry Point'
-
-
-
-
-
-
-
Caribou Biosciences, Inc. (CRBU) Misses Q4 EPS by 2c
-
-
-
-
-
-
-
Caribou Biosciences, Inc. (CRBU) Tops Q1 EPS by 1c
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Caribou, Inspirato, Kornit, and Alico and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

